{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T04:17:47Z","timestamp":1783397867581,"version":"3.54.6"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T00:00:00Z","timestamp":1776816000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ctro.science","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical and Translational Radiation Oncology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.ctro.2026.101178","type":"journal-article","created":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T15:56:36Z","timestamp":1776959796000},"page":"101178","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["A pilot study of [68Ga]Ga-DOTA-TATE PET-based radiation contouring for pituitary adenoma"],"prefix":"10.1016","volume":"59","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-2429-1066","authenticated-orcid":false,"given":"Bradley","family":"Eckelmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takwa","family":"Salem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"April","family":"Premo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaili","family":"Ranta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-6250-7618","authenticated-orcid":false,"given":"Colin","family":"Harari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Durkee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Larson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azam","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Pirasteh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8551-151X","authenticated-orcid":false,"given":"Michael C.","family":"Veronesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4237-2796","authenticated-orcid":false,"given":"Brett","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 2","key":"10.1016\/j.ctro.2026.101178_b0005","doi-asserted-by":"crossref","DOI":"10.1093\/neuonc\/not151","article-title":"CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2006-2010.","volume":"15","author":"Ostrom","year":"2013","journal-title":"Neuro Oncol"},{"issue":"8","key":"10.1016\/j.ctro.2026.101178_b0010","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","article-title":"The 2021 WHO classification of tumors of the central nervous system: a summary","volume":"23","author":"Louis","year":"2021","journal-title":"Neuro Oncol"},{"issue":"16","key":"10.1016\/j.ctro.2026.101178_b0015","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1001\/jama.2023.5444","article-title":"Diagnosis and management of pituitary adenomas: a review","volume":"329","author":"Tritos","year":"2023","journal-title":"J Am Med Assoc"},{"issue":"2","key":"10.1016\/j.ctro.2026.101178_b0020","doi-asserted-by":"crossref","first-page":"535","DOI":"10.3171\/2019.11.JNS192457","article-title":"Long-term outcomes after endoscopic endonasal surgery for nonfunctioning pituitary macroadenomas","volume":"134","author":"Gerges","year":"2020","journal-title":"J Neurosurg"},{"issue":"4","key":"10.1016\/j.ctro.2026.101178_b0025","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1227\/NEU.0000000000001386","article-title":"Congress of neurological surgeons systematic review and evidence-based guidelines on the management of patients with nonfunctioning pituitary adenomas: executive summary","volume":"79","author":"Aghi","year":"2016","journal-title":"Neurosurgery"},{"issue":"5","key":"10.1016\/j.ctro.2026.101178_b0030","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/s41574-023-00948-8","article-title":"Consensus guideline for the diagnosis and management of pituitary adenomas in childhood and adolescence: Part 1, general recommendations","volume":"20","author":"Korbonits","year":"2024","journal-title":"Nat Rev Endocrinol"},{"issue":"7","key":"10.1016\/j.ctro.2026.101178_b0035","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1210\/jc.2011-0251","article-title":"Radiation therapy in the management of pituitary adenomas","volume":"96","author":"Loeffler","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"1\u20132","key":"10.1016\/j.ctro.2026.101178_b0040","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.wneu.2013.01.127","article-title":"Efficacy and safety of higher dose stereotactic radiosurgery for functional pituitary adenomas: a preliminary report","volume":"82","author":"Grant","year":"2014","journal-title":"World Neurosurg"},{"issue":"3","key":"10.1016\/j.ctro.2026.101178_b0045","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.ijrobp.2013.06.2057","article-title":"Long-term outcomes of fractionated stereotactic radiation therapy for pituitary adenomas at the BC Cancer Agency","volume":"87","author":"Kim","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.ctro.2026.101178_b0050","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1002\/cncr.22860","article-title":"The efficacy of fractionated radiotherapy and stereotactic radiosurgery for pituitary adenomas: long-term results of 125 consecutive patients treated in a single institution","volume":"110","author":"Kong","year":"2007","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.ctro.2026.101178_b0055","doi-asserted-by":"crossref","first-page":"648","DOI":"10.3171\/2017.5.JNS163069","article-title":"Early versus late Gamma Knife radiosurgery following transsphenoidal surgery for nonfunctioning pituitary macroadenomas: a multicenter matched-cohort study","volume":"129","author":"Pomeraniec","year":"2018","journal-title":"J Neurosurg"},{"issue":"6","key":"10.1016\/j.ctro.2026.101178_b0060","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.3171\/2022.10.JNS221873","article-title":"Adjuvant versus on-progression Gamma Knife radiosurgery for residual nonfunctioning pituitary adenomas: a matched-cohort analysis","volume":"138","author":"Mantziaris","year":"2023","journal-title":"J Neurosurg"},{"issue":"1","key":"10.1016\/j.ctro.2026.101178_b0065","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/s13014-016-0710-y","article-title":"Target delineation and optimal radiosurgical dose for pituitary tumors","volume":"11","author":"Minniti","year":"2016","journal-title":"Radiat Oncol"},{"issue":"3","key":"10.1016\/j.ctro.2026.101178_b0070","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1007\/s11060-018-2925-2","article-title":"Outcome of partially irradiated recurrent nonfunctioning pituitary macroadenoma by gamma knife radiosurgery","volume":"139","author":"Shen","year":"2018","journal-title":"J Neurooncol"},{"issue":"1","key":"10.1016\/j.ctro.2026.101178_b0075","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.clon.2019.06.015","article-title":"Inter-observer variability in target volume delineations of benign and metastatic brain tumours for stereotactic radiosurgery: results of a national quality assurance programme","volume":"32","author":"Growcott","year":"2020","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"11","key":"10.1016\/j.ctro.2026.101178_b0080","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1080\/0284186X.2018.1473636","article-title":"Multi-institutional study of the variability in target delineation for six targets commonly treated with radiosurgery","volume":"57","author":"Sandstrom","year":"2018","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ctro.2026.101178_b0085","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1748-717X-6-10","article-title":"Quantitative assessment of inter-observer variability in target volume delineation on stereotactic radiotherapy treatment for pituitary adenoma and meningioma near optic tract","volume":"6","author":"Yamazaki","year":"2011","journal-title":"Radiat Oncol"},{"issue":"5","key":"10.1016\/j.ctro.2026.101178_b0090","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1002\/(SICI)1097-0215(19980529)76:5<620::AID-IJC2>3.0.CO;2-S","article-title":"Expression of somatostatin receptor subtypes in human brain tumors","volume":"76","author":"Dutour","year":"1998","journal-title":"Int J Cancer"},{"issue":"5","key":"10.1016\/j.ctro.2026.101178_b0095","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/0024-3205(94)00956-2","article-title":"Expression of mRNA for all five human somatostatin receptors (hSSTR1-5) in pituitary tumors","volume":"56","author":"Panetta","year":"1995","journal-title":"Life Sci"},{"issue":"3","key":"10.1016\/j.ctro.2026.101178_b0100","doi-asserted-by":"crossref","first-page":"523","DOI":"10.2967\/jnumed.117.191916","article-title":"PET\/MRI in the Diagnosis of Hormone-Producing Pituitary Microadenoma: a prospective pilot Study","volume":"59","author":"Wang","year":"2018","journal-title":"J Nucl Med"},{"issue":"6","key":"10.1016\/j.ctro.2026.101178_b0105","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1007\/s12149-013-0718-4","article-title":"Physiological and tumoral uptake of (68)Ga-DOTATATE: standardized uptake values and challenges in interpretation","volume":"27","author":"Kuyumcu","year":"2013","journal-title":"Ann Nucl Med"},{"issue":"1","key":"10.1016\/j.ctro.2026.101178_b0110","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ijrobp.2012.03.021","article-title":"Contribution of 68Ga-DOTATOC PET\/CT to target volume delineation of skull base meningiomas treated with stereotactic radiation therapy","volume":"85","author":"Graf","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.ctro.2026.101178_b0115","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.ijrobp.2005.12.006","article-title":"Improved target volume definition for fractionated stereotactic radiotherapy in patients with intracranial meningiomas by correlation of CT, MRI, and [68Ga]-DOTATOC-PET","volume":"65","author":"Milker-Zabel","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.ctro.2026.101178_b0120","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.ijrobp.2022.04.009","article-title":"(68)Ga-DOTATATE PET-based radiation contouring creates more precise radiation volumes for patients with meningioma","volume":"113","author":"Perlow","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"12","key":"10.1016\/j.ctro.2026.101178_b0125","doi-asserted-by":"crossref","first-page":"3662","DOI":"10.1007\/s00259-024-06783-x","article-title":"Joint EANM\/EANO\/RANO\/SNMMI practice guideline\/procedure standards for diagnostics and therapy (theranostics) of meningiomas using radiolabeled somatostatin receptor ligands: version 1.0","volume":"51","author":"Albert","year":"2024","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.ctro.2026.101178_b0130","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.radonc.2020.11.014","article-title":"ESTRO ACROP guideline for target volume delineation of skull base tumors","volume":"156","author":"Combs","year":"2021","journal-title":"Radiother Oncol"},{"issue":"12","key":"10.1016\/j.ctro.2026.101178_b0135","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1097\/RLU.0000000000000535","article-title":"CyberKnife radiosurgery planning of a secreting pituitary adenoma performed with (6)(8)Ga DOTATATE PET and MRI","volume":"39","author":"d'Amico","year":"2014","journal-title":"Clin Nucl Med"},{"issue":"6","key":"10.1016\/j.ctro.2026.101178_b0140","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1097\/RLU.0000000000003589","article-title":"68Ga-DOTATATE PET\/CT imaging of refractory pituitary macroadenoma invading the orbit","volume":"46","author":"Lybik","year":"2021","journal-title":"Clin Nucl Med"},{"issue":"1","key":"10.1016\/j.ctro.2026.101178_b0145","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s41824-021-00104-3","article-title":"The value of [68Ga]Ga-DOTA-TATE PET\/CT in diagnosis and management of suspected pituitary tumors","volume":"5","author":"Novruzov","year":"2021","journal-title":"Eur J Hybrid Imaging"},{"issue":"7","key":"10.1016\/j.ctro.2026.101178_b0150","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1097\/RLU.0000000000000457","article-title":"Comparison of (68)Ga DOTATATE to 18F-FDG uptake is useful in the differentiation of residual or recurrent pituitary adenoma from the remaining pituitary tissue after transsphenoidal adenomectomy","volume":"39","author":"Zhao","year":"2014","journal-title":"Clin Nucl Med"},{"issue":"10","key":"10.1016\/j.ctro.2026.101178_b0155","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16101877","article-title":"The value of PET\/CT in particle therapy planning of various tumors with SSTR2 receptor expression: comparative interobserver study","volume":"16","author":"Lutgendorf-Caucig","year":"2024","journal-title":"Cancers (Basel)"},{"issue":"6","key":"10.1016\/j.ctro.2026.101178_b0160","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1111\/cen.14425","article-title":"Pre- and postoperative (68) Ga-DOTATOC positron emission tomography for hormone-secreting pituitary neuroendocrine tumours","volume":"94","author":"Tjornstrand","year":"2021","journal-title":"Clin Endocrinol"},{"issue":"2","key":"10.1016\/j.ctro.2026.101178_b0165","first-page":"322","article-title":"Comparative PET Imaging for Radiosurgical Target Delineation in Residual Acromegaly","volume":"67","author":"Hesse","year":"2026","journal-title":"J Nucl Med"},{"key":"10.1016\/j.ctro.2026.101178_b0170","article-title":"[(68)Ga]Ga-DOTATATE PET\/CT and PET\/MR enhances the detection of pituitary ACTH-secreting adenomas in cushing's disease","volume":"17","author":"Zhang","year":"2026","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"4","key":"10.1016\/j.ctro.2026.101178_b0175","doi-asserted-by":"crossref","first-page":"637","DOI":"10.3803\/EnM.2024.2249","article-title":"68Ga-DOTATOC PET\/CT in the localization of pituitary tumors in Cushing's disease","volume":"40","author":"Kim","year":"2025","journal-title":"Endocrinol Metab (Seoul)"},{"issue":"3","key":"10.1016\/j.ctro.2026.101178_b0180","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1046\/j.1365-2362.2001.00786.x","article-title":"Somatostatin receptor subtype 2 and 5 in human GH-secreting pituitary adenomas: analysis of gene sequence and mRNA expression","volume":"31","author":"Corbetta","year":"2001","journal-title":"Eur J Clin Invest"},{"issue":"4","key":"10.1016\/j.ctro.2026.101178_b0185","first-page":"1386","article-title":"Somatostatin receptor subtype gene expression in pituitary adenomas","volume":"80","author":"Miller","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.ctro.2026.101178_b0190","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1007\/BF03351043","article-title":"Expression of somatostatin receptors on human pituitary adenomas in vivo and ex vivo","volume":"24","author":"Nielsen","year":"2001","journal-title":"J Endocrinol Invest"},{"issue":"5","key":"10.1016\/j.ctro.2026.101178_b0195","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1210\/jc.2011-3163","article-title":"Expression of Ki-67, PTTG1, FGFR4, and SSTR 2, 3, and 5 in nonfunctioning pituitary adenomas: a high throughput TMA, immunohistochemical study","volume":"97","author":"Ramirez","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.ctro.2026.101178_b0200","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1530\/eje.1.02313","article-title":"Quantitative analysis of somatostatin receptor subtype (SSTR1-5) gene expression levels in somatotropinomas and non-functioning pituitary adenomas","volume":"156","author":"Taboada","year":"2007","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"10.1016\/j.ctro.2026.101178_b0205","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s11102-023-01329-0","article-title":"[68 Ga]-DOTATATE PET\/MR-based evaluation of physiologic somatostatin receptor 2 expression in the adult pituitary gland as a function of age and sex in a prospective cohort","volume":"26","author":"Kim","year":"2023","journal-title":"Pituitary"}],"container-title":["Clinical and Translational Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S240563082600073X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S240563082600073X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T03:47:21Z","timestamp":1783396041000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S240563082600073X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":41,"alternative-id":["S240563082600073X"],"URL":"https:\/\/doi.org\/10.1016\/j.ctro.2026.101178","relation":{},"ISSN":["2405-6308"],"issn-type":[{"value":"2405-6308","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A pilot study of [68Ga]Ga-DOTA-TATE PET-based radiation contouring for pituitary adenoma","name":"articletitle","label":"Article Title"},{"value":"Clinical and Translational Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctro.2026.101178","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V. on behalf of European Society for Radiotherapy and Oncology.","name":"copyright","label":"Copyright"}],"article-number":"101178"}}